Ratings & Metrics
Financial Documents
Entity | Document Type | Tax ID |
---|---|---|
Helen Keller International | IRS Form 990 | 13-5562162 |
HKI Support | IRS Form 990 | 26-4676791 |
Helen Keller International | Consolidated Audited Financial Statements | Multiple |
Entity: Helen Keller International Document Type: IRS Form 990 Tax ID: 13-5562162 |
Entity: HKI Support Document Type: IRS Form 990 Tax ID: 26-4676791 |
Entity: Helen Keller International Document Type: Consolidated Audited Financial Statements Tax ID: Multiple |
Governance & Transparency
Top Salaries
Name | Title | Compensation | |
---|---|---|---|
1 | Kathy Spahn | President/CEO | $413,861 |
2 | Christopher Landry | Chief of Party, Suaahara | $302,710 |
3 | Nancy Haitch | VP, External Relations | $267,124 |
1 Name: Kathy Spahn Title: President/CEO Compensation: $413,861 |
2 Name: Christopher Landry Title: Chief of Party, Suaahara Compensation: $302,710 |
3 Name: Nancy Haitch Title: VP, External Relations Compensation: $267,124 |
Analysts' Notes
According to the Helen Keller International (HKI) consolidated audit of June 30, 2018 (Note 2, Contributions of Medical Supplies, Medicines and Other (In-Kind)): "Contributions of medical supplies consist of supplies received from major pharmaceutical companies and are used to fight and prevent blindness. ... During the years ended June 30, 2018 and 2017, HKI received and distributed $164,901,750 and $147,117,000, respectively, of the product Mectizan from a donor for the treatment of onchocerciasis..."
|